Caribou Biosciences (CRBU) Common Equity (2020 - 2026)
Caribou Biosciences' Common Equity was $98.1 million in Q2 2026, down 40.9% from $166.13 million a year earlier and down 3.8% from the prior quarter.
Powered by 
Analysis
Caribou Biosciences (CRBU) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Caribou Biosciences came in at $122.18 million, down 51.7% from FY2024.
- In earlier years, Common Equity was $252.95 million in FY2024 (-31.3%), $368.4 million in FY2023 (+22.4%), $300.87 million in FY2022 (-22.4%) and $387.83 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Common Equity since Q2 2021.
- Compared with a year earlier, Common Equity has declined for eight straight quarters, with an average decline of 42.4% over the last eight quarters.
- The best year-over-year quarter for Common Equity over five years was Q1 2024 (growth of 23.4%); the worst was Q1 2026 (a decline of 53.0%).
- Per Business Quant data, CRBU's Common Equity in the three quarters before Q2 2026 was $102.02 million (Q1 2026), $122.18 million (Q4 2025) and $141.85 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Caribou Biosciences | 56.06 Mn | -460.48 Mn | - | 98.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 98.10 Mn |
| Mar 31, 2026 | 102.02 Mn |
| Dec 31, 2025 | 122.18 Mn |
| Sep 30, 2025 | 141.85 Mn |
| Jun 30, 2025 | 166.13 Mn |
| Mar 31, 2025 | 217.22 Mn |
| Dec 31, 2024 | 252.95 Mn |
| Sep 30, 2024 | 281.20 Mn |
| Jun 30, 2024 | 310.46 Mn |
| Mar 31, 2024 | 343.29 Mn |
| Dec 31, 2023 | 368.40 Mn |
| Sep 30, 2023 | 398.27 Mn |
| Jun 30, 2023 | 269.46 Mn |
| Mar 31, 2023 | 278.27 Mn |
| Dec 31, 2022 | 300.87 Mn |
| Sep 30, 2022 | 324.11 Mn |
| Jun 30, 2022 | 347.89 Mn |
| Mar 31, 2022 | 371.80 Mn |
| Dec 31, 2021 | 387.83 Mn |
| Sep 30, 2021 | 404.40 Mn |
API Access
Caribou Biosciences Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CRBU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CRBU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CRBU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();